SEARCH

SEARCH BY CITATION

References

  • 1
    Baniel J, Grauss D, Engelstein D, Sella A. Intravesical bacillus Calmette-Guerin treatment for stage T1 grade3 transitional cell carcinoma of the bladder. Urology 1998; 52: 7859
  • 2
    Birch BRP, Harlands SJ. The pT1G3 bladder tumour. Br J Urol 1989; 64: 10916
  • 3
    Brake M, Loertzer H, Horsch R, Keller H. Recurrence and progression stage T1 grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin. J Urol 2000; 163: 1697701
  • 4
    Boccon-Gibod L, Leleu C, Herve JM et al. Bladder tumours invading the lamina propria (stage T1): influence of endovesical BCG therapy on recurrence and progression. Prog Clin Bio Res 1989; 310: 1619
  • 5
    Cookson MS, Sarosdy MF. Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy. J Urol 1992; 148: 797801
  • 6
    Dal Bo V, Belmonte, P, Veronesi A et al. Intravesical BCG instillations in patients with carcinoma in situ and pT1, G3 transitional cell carcinoma of the bladder. Eur Urol 1990; 18 (Suppl): 437
  • 7
    Eure GR, Cundiff MR, Schellhammer PF. Bacillus Calmette-Guerin therapy for high risk stage T1 superficial bladder cancer. J Urol 1992; 147: 3769
  • 8
    Gohji K, Nomi M, Okamoto M et al. Conservative therapy for stage T1b grade 3 transitional cell carcinoma of bladder. Urology 1999; 53: 30813
  • 9
    Heney NM, Ahmed S, Flanigan MJ et al. Superficial bladder cancer: progression and recurrence. J Urol 1983; 130: 10836
  • 10
    Herr HW, Schwalb DM, Zhang ZF et al. Intravesical bacillus Calmette-Guerin therapy prevents tumour progression and death from superficial bladder cancer: ten year follow up of a prospective randomized trial. J Clin Oncol 1995; 13: 14048
  • 11
    Herr HW. Tumour progression and survival in patients with T1G3 bladder tumour: 15-year outcome. Br J Urol 1997; 80: 7625
  • 12
    Hurle R, Losa A, Raniery A, Graziotti P, Lembo A. Low dose Pasteur Bacillus Calmette-Guerin regimen in stage T1 grade 3 bladder cancer therapy. J Urol 1996; 156: 16025
  • 13
    Hurle R, Losa A, Ranieri A, Graziotti P, Lembo A. Low dose Pasteur bacillus Calmette-Guerin regimen in stage T1 grade 3 bladder cancer therapy. Urology 2000; 55: 6738
  • 14
    Kamat MR, Kulkarni JN, Tongaonkar HB, Dalal AV. Intravesical bacillus Calmette-Guerin for superficial bladder cancer: experience with Danish 1331 strain: J Urol 1994; 152: 14248
  • 15
    Klan R, Steiner U, Sauter T et al. Zystektomie beim schlecht differenzierten T1-Harnblasenkarzinom-oft zu fruh? Akt Urol 1998; 29: 538
  • 16
    Samodai L, Kiss L, Kolozsy Z et al. The efficacy of intravesical BCG in the treatment of patients with high risk superficial bladder cancer. Int Urol Nephrol 1991; 23: 55967
  • 17
    Serretta V, Piazza S, Pavone C et al. Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1G3 transitional cell carcinoma of the bladder. Urology 1996; 47: 64751
  • 18
    Labret T, Gaudez F, Herve JM et al. Low dose BCG instillation in the treatment of stage T1 grade G3 bladder tumours: recurrence, progression and success. Eur Urol 1998; 34: 6772
  • 19
    Ovesen H, Poulsen AL, Steven K. Intravesical bacillus Calmette-Guerin with the Danish strains for treatment of carcinoma in situ of the bladder. Br J Urol 1993; 72: 7448
  • 20
    Pansadoro V, Emilozzi P, Defidio D et al. Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long term results. J Urol 1995; 154: 2054
  • 21
    Pham HT, Soloway MS. High risk superficial bladder cancer. intravesical therapy for T1G3 transitional cell carcinoma of the urinary bladder. Semin Urol Oncol 1997; 15: 14752
  • 22
    Bono AV, Lovisolo JA, Saredi G. Transurethral resection and sequential chemo immuno prophylaxis in primary T1 G3 bladder Cancer. Eur Urol 2000; 37: 47883
  • 23
    Morales A, Eidinger D, Bruce AW. Intracavitary BCG in treatment of superficial bladder tumour. J Urol 1976; 116: 1803
  • 24
    Kaubisch S, Lum BL, Reese J et al. Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion. J Urol 1991; 146: 2833
  • 25
    Jakse G, Loidl W, Seeber G et al. Stage T1 grade 3 transitional cell carcinoma of the bladder: an unfavourable tumour? J Urol 1987; 137: 3943
  • 26
    Malkowicz SB, Nichols P, Lieskovsky G et al. The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2): J Urol 1990; 144: 6415

Authors

  1. Authors

J.N. Kulkarni, MS, MCh(Urol), FICS, MNAMS, FCPS, Professor and Head.

R. Gupta, MCh(Urol), Resident.

Abbreviations
CIS

carcinoma in situ